Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
D012968:Etidronic Acid / Q000494:pharmacology*; D006801:Humans; D006961:Hyperparathyroidism / Q000378:metabolism*; D007015:Hypophosphatemia, Familial / Q000378:metabolism*; D007668:Kidney / Q000187:drug effects; D007684:Kidney Tubules / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D010001:Osteitis Deformans / Q000378:metabolism*; D010710:Phosphates / Q000378:metabolism*
D009943:Organophosphorus Compounds; D010710:Phosphates; D012968:Etidronic Acid